| mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
1 |
| mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
1 |
| mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
1 |
| mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
1 |
| mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
1 |